2023-503335-18-00
CTIS ↗
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia
Chronic myeloid leukemia
pharma · Solid Tumors, Colorectal Cancer and Breast Cancer · HER2 Mutant Non-small Cell Lung Cancer · ELVN
Enliven Therapeutics
Enliven Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Boulder, USA HQ
2019 Founded
75 Employees
Public company Type
ELVN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boulder, USA
- Founded
- 2019
- Employees
- 75
- Programs
- 6
- Drugs
- 13
- Patents
- 5
Enliven Therapeutics clinical trials
Registry index of 6 ClinicalTrials.gov studies linked to Enliven Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Enliven Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Enliven Therapeutics.